PVP-Guided Decongestive Therapy in HF 2

Condition(s) studied

Investigational drug(s) / intervention(s)

Diuretic therapy: Diuretic therapy will be tailored according to peripheral venous pressure targets or standard approach

Study summary

The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.

Eligibility

Primary outcome measure(s)

• Primary end point: Major adverse events (Mortality and rehospitalization) — One year
  The difference in the combined rate of all-cause mortality, all-cause hospitalization and all-cause emergency department visits

Trial sites (16)

More Başakşehir Çam & Sakura City Hospital trials in Turkey

Other trials for the same condition